Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 6483-15-4 Chemical Structure| 6483-15-4

Structure of Sophocarpine
CAS No.: 6483-15-4

Chemical Structure| 6483-15-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sophocarpine is a naturally-occuring HERG K+ channel blocker with IC50 ranging in 100-300 μM found from plant Sophora flavescens.

Synonyms: 13,14-Dehydromatrine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sophocarpine

CAS No. :6483-15-4
Formula : C15H22N2O
M.W : 246.35
SMILES Code : O=C1C=CC[C@]2([H])[C@@]3([H])CCCN4[C@@]3([H])[C@](CCC4)([H])CN21
Synonyms :
13,14-Dehydromatrine
MDL No. :MFCD00274555
InChI Key :AAGFPTSOPGCENQ-JLNYLFASSA-N
Pubchem ID :115269

Safety of Sophocarpine

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H312-H330
Precautionary Statements:P280-P310-P320-P405-P501
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Sophocarpine

PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Bone marrow-derived macrophages (BMM) 0, 0.25, 0.50, 1.00 mM 5 days To evaluate the effect of sophocarpine on RANKL-induced osteoclast formation, results showed that sophocarpine dose-dependently suppressed osteoclast formation. PMC5825302
Bone marrow-derived macrophages (BMM) 0.31 - 2 mM 48 or 96 h To evaluate the cytotoxicity of sophocarpine on bone marrow-derived macrophages, results showed no toxicity up to the maximal concentration. PMC5825302
Rat aortic endothelial cells 0.125 mmol/L 48 h Sophocarpine suppressed AGEs-induced apoptosis in RAECs and restored the activation of MKK3/6-p38MAPK/Nrf2 antioxidative signaling pathway. PMC5779049
Hepatic stellate cells 1μM and 2μM 24 h To study the effect of sophocarpine on LPS-stimulated hepatic stellate cells, it was found that sophocarpine significantly inhibited LPS-induced mRNA expression of PI3K, AKT, Cyto-C, Apaf1, caspase-9, and caspase-3, and reduced cell apoptosis. PMC5976937
Neonatal mouse cardiomyocytes (NMCMs) 1 mM 12 h To assess the effect of SPC on HG-induced inflammatory responses, results showed SPC significantly inhibited the HG-induced increase in inflammatory markers PMC6836764
H9c2 cells 1 mM 12 h To assess the effect of SPC on HG-induced inflammatory responses, results showed SPC significantly inhibited the HG-induced increase in inflammatory markers PMC6836764
H9c2 cells 0.01–10 mM 48 or 96 h To assess the cytotoxicity of SPC, results showed no toxic effects of SPC on H9c2 cells up to the maximal concentration of 10 mM PMC6836764
Activated hepatic stellate cells 100-1000 μg/mL 0-5 days Sophocarpine significantly suppressed the proliferation of HSCs and down-regulated the expression of Cyclin D1 and PCNA. PMC3930980
Hepatic stellate cells (HSCs) 25, 50, 200 mg/mL 48 or 72 h Sophocarpine inhibited the activation and proliferation of HSCs and decreased the expression of α-SMA, collagen Ⅰ and Ⅲ, TGF-β1, IL-6, TNF-α and MCP-1. PMC3930980

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rat Rat femoral particle-induced peri-implant osteolysis model Intraperitoneal injection 20 mg/kg Once daily for 12 weeks To evaluate the effect of sophocarpine on particle-induced implant loosening, results showed that sophocarpine prevented prosthesis loosening by inhibiting osteoclast formation, resulting in reduced periprosthetic bone loss, diminished pseudomembrane formation, improved bone-implant contact, and enhanced stability of implants. PMC5825302
Nude mice UM-SCC-22B xenograft model Intravenous injection 5 mg/kg Every other day for 21 days SC significantly inhibited tumor growth without observable tissue toxicity. PMC5589060
Sprague-Dawley rats AGEs-induced aortic endothelial cell apoptosis model Intraperitoneal injection 40 mg/kg Once daily for 10 days Sophocarpine alleviated AGEs-induced aortic endothelial cell apoptosis and restored the activation of MKK3/6-p38MAPK/Nrf2 antioxidative signaling pathway. PMC5779049
C57 BL/6 mice LPS-induced septic liver injury model Oral 30 mg/kg and 60 mg/kg Once daily for 24 days To investigate the protective effect of sophocarpine on LPS-induced liver injury in mice, it was found that sophocarpine significantly improved the survival rate of mice, attenuated liver injury, and reduced oxidative stress, inflammation, and apoptosis. PMC5976937
C57BL/6 mice Streptozotocin (STZ)-induced type 1 diabetes mellitus mouse model Intraperitoneal injection 20 mg/kg Once daily for 16 weeks To assess the effect of SPC on diabetes-induced cardiac dysfunction, results showed SPC significantly improved cardiac function in diabetic mice PMC6836764
BALB/C mice ConA-induced hepatitis model Oral 30 and 60 mg/kg Five consecutive days Sophocarpine significantly attenuated ConA-induced hepatitis by inhibiting inflammatory mediators, chemokines, and the STAT1 signaling pathway. PMC5359249
Rats Dimethylnitrosamine (DMN) or bile duct ligation (BDL) induced liver fibrosis models Intraperitoneal injection 20 mg/kg Once daily for 3 weeks (BDL) or 4 weeks (DMN) Sophocarpine improved liver function, reduced collagen deposition, inhibited the development of hepatic fibrosis, and down-regulated the expression of TLR4 signaling pathway-related proteins. PMC3930980
Mice Isoproterenol-induced kidney injury model Intraperitoneal injection 20 mg/kg and 40 mg/kg Once daily for two weeks Sophocarpine alleviates isoproterenol-induced kidney injury by suppressing inflammation, apoptosis, oxidative stress, and fibrosis PMC9694211

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.06mL

0.81mL

0.41mL

20.30mL

4.06mL

2.03mL

40.59mL

8.12mL

4.06mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories